Raúl Martínez-CastroGilberto Barranco-LampónLuara L. Arana-LunaJosé L. Álvarez-VeraFlavio Rojas-CastillejosRosalinda Peñaloza-RamírezAdrián A. Carballo‐ZarateIrma Olarte-CarrilloJaime Israel-García MinamyJavier López‐Salazar2026-03-222026-03-22202310.24875/gmm.m22000808https://doi.org/10.24875/gmm.m22000808https://andeanlibrary.org/handle/123456789/73972Patients with myeloproliferative neoplasms have an increased risk of thrombosis and bleeding. This risk must be identified, as well as individualizing the therapeutic strategy before invasive procedures; adequate cytoreduction reduces the risk of complications.esMedicineThrombosisIntensive care medicineRisk assessmentSurgeryarticle